Adma Biologics reported $196.67M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Adma Biologics USD 196.67M 5.21M Sep/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
BioCryst Pharmaceuticals USD 5.23M 188K Sep/2025
Novavax USD 13.51M 3.27M Sep/2025
Omeros USD 712K 266K Sep/2021
Takeda JPY 1.41T 107.71B Dec/2025